We are live on ! Find out more
VYGR icon

Voyager Therapeutics
VYGR

78 hedge funds and large institutions have $127M invested in Voyager Therapeutics in 2022 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 16 increasing their positions, 27 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

616% more call options, than puts

Call options by funds: $4.43M | Put options by funds: $619K

57% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 14

11% more funds holding

Funds holding: 70 → 78 (+8)

3.66% more ownership

Funds ownership: 58.95% → 62.61% (+3.7%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

26% less capital invested

Capital invested by funds: $171M → $127M (-$44.1M)

41% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 27

Holders
78
Holders Change
+8
Holders Change %
+11.43%
% of All Funds
1.31%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
22
Increased
16
Reduced
27
Closed
14
Calls
$4.43M
Puts
$619K
Net Calls
+$3.81M
Net Calls Change
+$593K

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$8.08M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$5.29M
3
Millennium Management
Millennium Management
New York
+$4.37M
4
AC
Armistice Capital
New York
+$3.81M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$888K

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$7.09M
2
EI
EAM Investors
California
-$2.59M
3
Marshall Wace
Marshall Wace
United Kingdom
-$2.33M
4
EGI
EAM Global Investors
California
-$1.71M
5
CSS
Cubist Systematic Strategies
Connecticut
-$1.02M
Name Holding Trade Value Shares
Change 		Change in
Stake
BNP Paribas Financial Markets
76
BNP Paribas Financial Markets
France
$910 -$101 -15 -9%
EI
77
EAM Investors
California
– -$2.59M -339,497 Closed
Marshall Wace
78
Marshall Wace
United Kingdom
– -$2.33M -305,445 Closed
EGI
79
EAM Global Investors
California
– -$1.71M -224,825 Closed
AG
80
Algert Global
California
– -$218K -28,650 Closed
Citigroup
81
Citigroup
New York
– -$186K -24,461 Closed
Man Group
82
Man Group
United Kingdom
– -$157K -20,602 Closed
Squarepoint
83
Squarepoint
New York
– -$153K -20,066 Closed
TRCT
84
Tower Research Capital (TRC)
New York
– -$147K -19,339 Closed
VF
85
Virtu Financial
New York
– -$141K -18,443 Closed
KOC
86
Koss-Olinger Consulting
Florida
– -$134K -17,636 Closed
HF
87
HRT Financial
New York
– -$97K -12,782 Closed
TSS
88
Two Sigma Securities
New York
– -$86K -11,268 Closed
FWM
89
Focused Wealth Management
New York
– -$76K -10,000 Closed
PFS
90
Prospera Financial Services
Texas
– -$5K -600 Closed
1 2 3
4

VYGR Hedge Fund Activity: Q2 2022 in Review

78 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q2 2022, worth a combined $127M — down 26% from $171M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new VYGR positions and 14 closed out — a net gain of 8 holders — while 16 added to existing stakes and 27 trimmed.

The largest buyer was EcoR1 Capital, adding an estimated $8.08M. The largest seller was BVF Inc, cutting an estimated $7.09M.

  • 78 institutional investors held Voyager Therapeutics (VYGR) as of Q2 2022, up from 70 in Q1 2022.
  • Funds reported $127M of Voyager Therapeutics stock for Q2 2022, down 26% quarter-over-quarter.
  • 22 funds opened new Voyager Therapeutics positions in Q2 2022 and 14 closed out, a net change of +8 holders.
  • The largest Voyager Therapeutics buyer in Q2 2022 was EcoR1 Capital, an estimated $8.08M added.
  • The largest Voyager Therapeutics seller in Q2 2022 was BVF Inc, an estimated $7.09M sold.

Based on aggregated 13F filings for Q2 2022.